Author:
Brown Carolyn M.,Nwokeji Esmond,Rascati Karen L.,Zachry Woodie,Phillips Glenn A.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Health Policy,Pshychiatric Mental Health
Reference31 articles.
1. Bernasek, C., Farkas, J., Felman, H., et al. (2003). Case study: Michigan’s Medicaid prescription drug benefit. Washington, DC: Henry Kaiser Family Foundation.
2. Brown, C., Richards, K., Rascati, K., Gavaza, P., Corbell, Z., Zachry, W., et al. (2008). Effects of a psychotherapeutic drug Prior Authorization (PA) requirement on patients and providers: A providers’ perspective. Administration and Policy in Mental Health and Mental Health Services Research, 35, 181–188. doi: 10.1007/s10488-007-0158-3 .
3. Churchill, G. A. (1979). A paradigm for developing better measures of marketing constructs. JMR, Journal of Marketing Research, 16, 64–73. doi: 10.2307/3150876 .
4. Delate, T., Mager, D. E., Sheth, J., & Motheral, B. R. (2005). Clinical and financial outcomes associated with a proton pump inhibitor prior-authorization program in a Medicaid population. The American Journal of Managed Care, 11, SP29–SP36.
5. Ferketich, S. (1991). Focus on psychometrics: Aspects of item analysis. Research in Nursing and Health, 14, 165–168. doi: 10.1002/nur.4770140211 .
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献